CHINA PHARMA HLDGS INC's ticker is CPHI and the CUSIP is 16941T104. A total of 10 filers reported holding CHINA PHARMA HLDGS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $33 | -99.9% | 340,417 | -6.6% | 0.00% | – |
| Q3 2022 | $47,000 | -30.9% | 364,459 | +14.3% | 0.00% | – |
| Q2 2022 | $68,000 | -50.7% | 318,812 | -10.1% | 0.00% | – |
| Q1 2022 | $138,000 | -37.8% | 354,617 | -22.9% | 0.00% | – |
| Q4 2021 | $222,000 | -43.2% | 460,217 | -34.3% | 0.00% | -100.0% |
| Q3 2021 | $391,000 | +10.8% | 700,649 | +43.7% | 0.00% | – |
| Q2 2021 | $353,000 | -17.1% | 487,479 | -3.9% | 0.00% | -100.0% |
| Q1 2021 | $426,000 | +20.3% | 507,279 | -36.1% | 0.00% | – |
| Q4 2020 | $354,000 | +33.1% | 793,879 | +9.0% | 0.00% | – |
| Q3 2020 | $266,000 | -52.3% | 728,580 | -13.1% | 0.00% | – |
| Q2 2020 | $558,000 | +16.5% | 838,080 | -11.8% | 0.00% | – |
| Q1 2020 | $479,000 | +125.9% | 950,080 | +6.3% | 0.00% | – |
| Q4 2019 | $212,000 | +18.4% | 893,463 | +22.1% | 0.00% | – |
| Q3 2019 | $179,000 | -27.2% | 731,457 | -3.9% | 0.00% | – |
| Q2 2019 | $246,000 | -4.7% | 760,777 | -2.3% | 0.00% | – |
| Q1 2019 | $258,000 | +100.0% | 778,938 | +55.7% | 0.00% | – |
| Q4 2018 | $129,000 | +29.0% | 500,438 | +1.9% | 0.00% | – |
| Q3 2018 | $100,000 | -66.3% | 491,106 | -55.0% | 0.00% | – |
| Q2 2018 | $297,000 | +60.5% | 1,091,792 | +87.4% | 0.00% | – |
| Q1 2018 | $185,000 | +96.8% | 582,700 | +8.9% | 0.00% | – |
| Q4 2017 | $94,000 | +22.1% | 535,100 | +21.0% | 0.00% | – |
| Q3 2017 | $77,000 | -1.3% | 442,300 | +30.9% | 0.00% | – |
| Q2 2017 | $78,000 | +77.3% | 338,000 | +99.5% | 0.00% | – |
| Q1 2017 | $44,000 | +25.7% | 169,400 | +26.8% | 0.00% | – |
| Q4 2016 | $35,000 | +34.6% | 133,600 | +11.2% | 0.00% | – |
| Q3 2016 | $26,000 | +13.0% | 120,100 | +26.0% | 0.00% | – |
| Q2 2016 | $23,000 | +43.8% | 95,300 | +1.3% | 0.00% | – |
| Q1 2016 | $16,000 | 0.0% | 94,100 | -8.0% | 0.00% | – |
| Q4 2015 | $16,000 | -27.3% | 102,300 | -6.0% | 0.00% | – |
| Q3 2015 | $22,000 | -50.0% | 108,800 | -11.2% | 0.00% | – |
| Q2 2015 | $44,000 | -2.2% | 122,500 | -7.2% | 0.00% | – |
| Q1 2015 | $45,000 | +9.8% | 132,000 | -3.2% | 0.00% | – |
| Q4 2014 | $41,000 | +5.1% | 136,300 | -11.8% | 0.00% | – |
| Q3 2014 | $39,000 | -30.4% | 154,500 | +5.3% | 0.00% | – |
| Q2 2014 | $56,000 | -30.0% | 146,700 | -7.1% | 0.00% | – |
| Q1 2014 | $80,000 | +50.9% | 157,900 | +3.6% | 0.00% | – |
| Q4 2013 | $53,000 | +10.4% | 152,400 | -11.0% | 0.00% | – |
| Q3 2013 | $48,000 | +29.7% | 171,300 | -3.6% | 0.00% | – |
| Q2 2013 | $37,000 | – | 177,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 58,693 | $42,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 195,000 | $141,000 | 0.00% |
| HRT FINANCIAL LP | 260,918 | $188,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 28,803 | $21,000 | 0.00% |
| MORGAN STANLEY | 500 | $0 | 0.00% |
| Citadel Advisors | 46,030 | $33,000 | 0.00% |
| Renaissance Technologies | 487,479 | $353,000 | 0.00% |
| UBS Group AG | 15,416 | $11,000 | 0.00% |